Long-term treatment of systemic juvenile idiopathic arthritis with tocilizumab: results of an open-label extension study in Japan

被引：37
|
作者：
Yokota, Shumpei [1 ]
Imagawa, Tomoyuki [1 ]
Mori, Masaaki [2 ]
Miyamae, Takako [1 ]
Takei, Syuji [3 ]
Iwata, Naomi [4 ]
Umebayashi, Hiroaki [5 ]
Murata, Takuji [6 ]
Miyoshi, Mari [7 ]
Tomiita, Minako [8 ]
Nishimoto, Norihiro [9 ]
Kishimoto, Tadamitsu [10 ]
机构：
[1] Yokohama City Univ, Sch Med, Dept Paediat, Yokohama, Kanagawa 2360004, Japan
[2] Yokohama City Univ, Med Ctr, Dept Paediat, Yokohama, Kanagawa 2360004, Japan
[3] Kagoshima Univ, Sch Hlth Sci, Kagoshima 890, Japan
[4] Aichi Childrens Hlth & Med Ctr, Aichi, Japan
[5] Miyagi Childrens Hosp, Sendai, Miyagi, Japan
[6] Osaka Med Coll, Dept Paediat, Osaka, Japan
[7] Kobe Childrens Hosp, Kobe, Hyogo, Japan
[8] Chiba Univ, Grad Sch Med, Dept Paediat, Chiba, Japan
[9] Wakayama Med Univ, Lab Immune Regulat, Osaka, Japan
[10] Osaka Univ, Immunol Frontier Res Ctr, Osaka, Japan
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2013年 / 72卷 / 04期
关键词：
RHEUMATOID-ARTHRITIS; DOUBLE-BLIND; SAFETY; ETANERCEPT; CATEGORIES; DISEASE; TRIAL;
D O I：
10.1136/annrheumdis-2012-202310
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：627 / 628
页数：2
相关论文
共 50 条
  • [41] An Open-Label Trial to Assess the Efficacy and Safety of Tocilizumab in the Management of Juvenile Idiopathic Arthritis-Associated Uveitis: Preliminary Results
    Suhler, Eric B.
    Giles, Tracy R.
    Lin, Phoebe
    Shifera, Amde Selassie
    Rosenbaum, James T.
    [J]. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2015, 56 (07)
  • [42] Persistence of Tofacitinib in the Treatment of Rheumatoid Arthritis in Open-Label, Long-Term Extension Studies up to 8 Years
    Pope, Janet
    Keystone, Edward
    Jamal, Shahin
    Wang, Lisy
    Fallon, Lara
    Woolcott, John
    Lazariciu, Irina
    Haraoui, Boulos
    [J]. ARTHRITIS & RHEUMATOLOGY, 2016, 68
  • [43] BARICITINIB, AN ORAL JANUS KINASE INHIBITOR, IN THE TREATMENT OF RHEUMATOID ARTHRITIS: SAFETY AND EFFICACY IN OPEN-LABEL, LONG-TERM EXTENSION STUDY
    Taylor, P.
    Genovese, M. C.
    Keystone, E.
    Schlichting, D.
    Beattie, S.
    Macias, W.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 : 65 - 66
  • [44] Baricitinib, an oral janus kinase inhibitor, in the treatment of rheumatoid arthritis: safety and efficacy in an open-label, long-term extension study
    Taylor, P.
    Genovese, M.
    Keystone, E.
    Schlichting, D.
    Beattie, S.
    Macias, W.
    Lundmark, J.
    [J]. SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 2014, 43 : 59 - 59
  • [45] BARICITINIB, AN ORAL JANUS KINASE INHIBITOR, IN THE TREATMENT OF RHEUMATOID ARTHRITIS: SAFETY AND EFFICACY IN AN OPEN-LABEL, LONG-TERM EXTENSION STUDY
    Taylor, Peter
    Genovese, Mark
    Keystone, Ed
    Schlichting, Douglas
    Beattie, Scott
    Macias, William
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 : A31 - A31
  • [46] Long-term safety and tolerability of nintedanib in patients with idiopathic pulmonary fibrosis: results from the open-label extension study, INPULSIS-ON
    Crestani, Bruno
    Huggins, John T.
    Kaye, Mitchell
    Costabel, Ulrich
    Glaspole, Ian
    Ogura, Takashi
    Song, Jin Woo
    Stansen, Wibke
    Quaresma, Manuel
    Stowasser, Susanne
    Kreuter, Michael
    [J]. LANCET RESPIRATORY MEDICINE, 2019, 7 (01): : 60 - 68
  • [47] Predictive Markers Of Joint Damages Of Children With Systemic-Onset Juvenile Idiopathic Arthritis In Long-Term Course Of Treatment With Tocilizumab
    Nozawa, Tomo
    Kanetaka, Taichi
    Nishimura, Kenichi
    Kikuchi, Masako
    Sato, Tomomi
    Sakurai, Nodoka
    Hara, Ryoki
    Yamazaki, Kazuko
    Yokota, Shumpei
    [J]. ARTHRITIS AND RHEUMATISM, 2013, 65 : S113 - S113
  • [48] LONG-TERM SAFETY AND EFFECTIVENESS OF LURASIDONE IN SCHIZOPHRENIA: RESULTS OF A 22 MONTH, OPEN-LABEL EXTENSION STUDY
    Pikalov, Andrei
    Correll, Christoph
    Cucchiaro, Josephine
    Silva, Robert
    Hsu, Jay
    Loebel, Antony
    [J]. SCHIZOPHRENIA RESEARCH, 2014, 153 : S178 - S178
  • [49] ABP 501 Long-Term Safety/Efficacy: Interim Results from an Open-Label Extension Study
    Cohen, Stanley
    Pablos, Jose L.
    Zhang, Nan
    Rizzo, Warren
    Muller, Gerhard
    Padmanaban, Devi
    Kivitz, Alan
    Matsumoto, Alan K.
    Kaur, Primal
    [J]. ARTHRITIS & RHEUMATOLOGY, 2016, 68
  • [50] LONG-TERM SAFETY AND EFFECTIVENESS OF LURASIDONE IN SCHIZOPHRENIA: RESULTS OF A 22 MONTH, OPEN-LABEL EXTENSION STUDY
    Correll, C.
    Cucchiaro, J.
    Silva, R.
    Hsu, J.
    Pikalov, A.
    Loebel, A.
    [J]. EUROPEAN PSYCHIATRY, 2014, 29
12345